There's always Genta, pushing $1B in deficit, trading for a penny with 2B+ shares outstanding, negative net cash and oblivious shareholders. Not to mention the most active “biotech” board on iHub: <a href="http://investorshub.advfn.com/boards/most_read.aspx" target="_blank">http://investorshub.advfn.com/boards/most_read.aspx</a> As the saying goes, hydrogen and stupidity :- )